London
· Delayed Price · Currency is GBP · Price in USD Abeona Therapeutics Statistics
Total Valuation
LON:0H7R has a market cap or net worth of GBP 192.35 million. The enterprise value is 136.20 million.
| Market Cap | 192.35M |
| Enterprise Value | 136.20M |
Important Dates
The next estimated earnings date is Tuesday, May 13, 2025.
| Earnings Date | May 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +91.99% |
| Shares Change (QoQ) | +1.24% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 34.20M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 5.47 |
| P/TBV Ratio | 5.47 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -2.68 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -2.92 |
Financial Position
The company has a current ratio of 6.08, with a Debt / Equity ratio of 0.52.
| Current Ratio | 6.08 |
| Quick Ratio | 5.99 |
| Debt / Equity | 0.52 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.39 |
| Interest Coverage | -15.26 |
Financial Efficiency
Return on equity (ROE) is -216.57% and return on invested capital (ROIC) is -91.93%.
| Return on Equity (ROE) | -216.57% |
| Return on Assets (ROA) | -46.41% |
| Return on Invested Capital (ROIC) | -91.93% |
| Return on Capital Employed (ROCE) | -69.53% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -374,329 |
| Employee Count | 136 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +15.17% in the last 52 weeks. The beta is 1.70, so LON:0H7R's price volatility has been higher than the market average.
| Beta (5Y) | 1.70 |
| 52-Week Price Change | +15.17% |
| 50-Day Moving Average | 5.19 |
| 200-Day Moving Average | 5.62 |
| Relative Strength Index (RSI) | 50.24 |
| Average Volume (20 Days) | 29,010 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 2.11 |
Income Statement
| Revenue | n/a |
| Gross Profit | -27.45M |
| Operating Income | -51.29M |
| Pretax Income | -50.91M |
| Net Income | -50.91M |
| EBITDA | -49.69M |
| EBIT | -51.29M |
| Earnings Per Share (EPS) | -1.24 |
Balance Sheet
The company has 78.06 million in cash and 18.41 million in debt, giving a net cash position of 59.65 million.
| Cash & Cash Equivalents | 78.06M |
| Total Debt | 18.41M |
| Net Cash | 59.65M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 35.17M |
| Book Value Per Share | 0.77 |
| Working Capital | 67.31M |
Cash Flow
In the last 12 months, operating cash flow was -44.74 million and capital expenditures -1.95 million, giving a free cash flow of -46.70 million.
| Operating Cash Flow | -44.74M |
| Capital Expenditures | -1.95M |
| Free Cash Flow | -46.70M |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
LON:0H7R does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -91.99% |
| Shareholder Yield | -91.99% |
| Earnings Yield | -26.47% |
| FCF Yield | -24.28% |
Stock Splits
The last stock split was on July 5, 2022. It was a reverse split with a ratio of 0.04.
| Last Split Date | Jul 5, 2022 |
| Split Type | Reverse |
| Split Ratio | 0.04 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |